Open AccessAbstract CT083: Camrelizumab plus apatinib in extensive-stage small-cell lung cancer (PASSION): A multicenter, two-stage, phase 2 trial
Author(s) -
Jie Wang,
Yun Fan,
Jun Zhao,
Qiming Wang,
Dingzhi Huang,
Xingya Li,
Jianhua Chen,
Yong Fang,
Zhijie Wang,
Caicun Zhou,
Yanping Hu,
Haihua Yang,
Yi Hu,
Jianying Zhou,
Xiaoyan Lin,
Lifeng Wang,
Yanjun Xu,
Hanying Li
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct083
Subject(s) - medicine , apatinib , tolerability , cohort , surgery , progression free survival , lung cancer , cancer , gastroenterology , chemotherapy , oncology , adverse effect